The Brookline Capital Markets Group has extensive experience providing capital markets and advisory services to public and private life sciences, medical technology, and diagnostics companies, Special Purpose Acquisition Companies (“SPACs”), and other emerging growth enterprises.

Brookline is recognized for its differentiated ability to source capital from traditional institutional investors, as well as from its proprietary network of global family offices and high net worth investors. Our greatest source of pride is the success and longevity of our clients as they grow and flourish.